u/raytoei

DPZ shares down ~40% in past year; now 14x forward earnings vs ~20x for peers; market share among top 3 pizza chains rose from 38% to 54% (2016–2025); franchisee EBITDA per unit is $166k vs Pizza Hut’s $55k; free cash flow $672M. Market overreacts to sales slowdown (0.9% same-store growth) and CEO change; asset-light model and buybacks sustain EPS growth; valuation at multi-year low. Patient investors can buy DPZ as a reliable cash compounder at a depressed multiple; industry consolidation benefits the strongest player. Continued sales deceleration, aggressive discounting by rivals, failure to reset growth targets, further margin compression. TICKER - YUMC - LONG | confidence: 0.60 | sentiment: +0.70 Speaker: u/raytoei Thesis: Author explicitly bought a tracker stock in Yum China (YUMC) because Yum Brands sold Pizza Hut globally, but Yum China retains rights in China; sale may unlock value. Yum China stands to benefit from owning the Pizza Hut brand in a growing market, while the parent sale refocuses the business. Author’s personal position signals a bullish view on Yum China’s Pizza Hut assets in China. China macroeconomic slowdown, regulatory changes, competitive pressure from local chains, execution risk.

Advanced Micro Devices will also leave the Russell 1000 Value Index and become pure growth. Similar forced selling dynamic as GOOGL; value funds must reduce or eliminate exposure. Short-term bearish due to passive rebalance outflows before the June 29 deadline. Strong secular AI demand could attract growth fund buying that offsets selling; AMD is volatile.

RDDT reported adjusted EPS of $1.01 (vs. $0.57 est.), revenue $663M (vs. $608M est.), and Q2 guidance above consensus; ad revenue grew 74% YoY. The stock has fallen 36% YTD into “value territory,” but the earnings beat and positive guidance may reverse the downtrend, especially with the author’s multiple buys at lower levels. A beaten-down growth stock with a strong quarterly surprise could see a short-term price recovery; the author is betting on mean reversion and underlying business momentum. Slowing DAU growth (17% YoY vs 30.7% prior), AI competition replacing user-generated content, and weak market sentiment for social media names.

Hidden Valley Ranch sales jumped 20%+ in June 2026, per Clorox, driven by World Cup tourists discovering ranch and TSA-related publicity. This unexpected demand spike for a high-margin consumer product could positively impact Clorox’s next quarterly earnings, especially if momentum continues through summer events. Short-term bullish catalyst from World Cup and 250th anniversary celebrations; potential for continued international expansion via "ranchbassadors" program. The sales bump may be temporary (event-driven); ranch is a mature category; Clorox faces broader headwinds in cleaning/bleach segments; Kraft Heinz competing with TSA-compliant packets.

The PHLX Semiconductor Index (SOX) is down 19% from its June peak, and Micron has lost $407B in market cap since June 25. Semiconductor ETF SMH tracks the SOX closely; continued downside momentum in the sector creates a short opportunity. Short SMH to profit from the accelerating tech rout as momentum turns negative across chip stocks. A sharp relief rally from oversold conditions, or positive AI earnings from TSMC/others could reverse sentiment. Ticker: QQQ - SHORT | confidence: 0.55 | sentiment: -0.70 Speaker: u/raytoei Thesis: The Mag 7 are derailed (Alphabet -4.4%, Meta, Amazon, Nvidia all down) and AI trade is getting hit by bad news. QQQ is the broad tech-heavy ETF; the selloff is spreading beyond semiconductors to large-cap tech leaders. Short QQQ to capture the broader tech rout as AI optimism fades and earnings risk looms. S&P 500 has held up OK, so rotation into non-tech sectors could limit QQQ downside; also a sudden positive catalyst (e.g., strong Google earnings) could trigger a squeeze.

AGCO was initiated with Buy and $160 target (40% upside from ~$114). Analyst notes AGCO’s Europe business is healthier than North America/Brazil. The new coverage and specific price target create a clear catalyst, and the stock is up only 8% YTD, leaving more room relative to DE. AGCO offers higher upside potential due to lower prior run-up and a fresh analyst catalyst, with European diversity cushioning the North American trough. European ag slowdown, currency headwinds, or failure of the U.S. turnaround to materialize; lower liquidity than DE.

Deere earned ~$35/share in FY23, fell to <$19 in FY25, and FY26 estimates have been cut to ~$18 but are expected to trough in 2026 with recovery in 2027. Analyst Shlisky rates DE Buy, implying that the worst of the earnings cycle is priced in and future cash flows will improve as farmer incomes rebound. Buying Deere at the cyclical trough before fundamentals inflect offers a classic value trade with potential for multiple expansion and earnings growth. Prolonged low crop prices, higher input costs, or a global recession delaying the recovery; China/Europe demand shocks.

WD-40 reported fiscal Q3 revenue of $195.1M (beat $172.8M consensus), EPS $2.33 (beat $1.56), and raised FY EPS guidance to $6.05–$6.35. Despite being a low-tech consumer staple, WD-40 is delivering double-digit sales growth globally and adopting AI internally, creating a classic value/growth hybrid opportunity. The stock surged 12% on the earnings beat, but the raised guidance and strong operational momentum suggest further upside relative to overvalued AI names. Consumer spending slowdown, raw material cost inflation, or a broader market rotation back into tech could cap gains.

Midera trades at ~11x 2026 EBITDA, below S&P 500 (15x) and parent Middleby (13x); management targets 5-7% annual sales growth and 5pp margin expansion through 2028. Spin-offs often trade at a discount due to newness and low liquidity, creating an entry point. The fragmented $70B market (top 5 players only 10% share) provides a clear M&A runway. Buy MFP as a small-cap value play with multiple catalysts: cheap valuation, recurring revenue from parts/service (40% of sales), and management's execution potential. Execution risk on margin targets; spin-off volatility in early trading; slower organic growth if food processing capex weakens. No other actionable trade ideas in this post.

Honeywell trades at ~19x forward earnings while comparable automation (EMR, ROK, SBGSY) and aerospace peers average ~25x; breakup is expected by June 29. The separation eliminates conglomerate discount, allows each unit to be valued on its own merit, and targets mid-single-digit revenue growth with margin expansion. The catalyst (spin-off date) is near-term, with potential for multiple expansion as the market reprices HON closer to peer multiples. Execution risk – margins may not hit 24% / 6-8% growth; broader market downturn; spin-off could be delayed or terms unfavorable.

Micron is up 225% YTD (as of article date), a “parabolic” move in a cyclical commodity semiconductor stock with no commensurate earnings growth. Such extreme price action often precedes sharp reversals; the article explicitly calls out this “flashing yellow light” and the overall chip mania. Short Micron as a bet that the bubble in DRAM/memory names will deflate, returning to more normal valuation multiples. AI-driven demand for HBM could sustain revenue growth; short squeezes in a still-hyped sector may delay the pullback.

Consumer spending at LULU declined in Q1, worsened in May; analysts cite incoherent designs and lower-quality fabric as key reasons for falling interest. Continued sales weakness and unresolved board/CEO issues will pressure the stock further, likely extending the downtrend. Short LULU on expectation of further earnings misses and negative momentum until a clear turnaround catalyst appears. A sudden CEO-led restructuring or buyout could reverse sentiment; seasonal athletic wear demand may surprise.

BSX trades at ~$57 vs Morningstar fair value of $81 and CFRA $67.63; EPS CAGR estimated 11-16% over next 5 years; CEO Mahoney has driven 16% EPS growth since 2010 with 85% accuracy. Valuation gap (discount to fair value) combined with strong product moats (PFA, WATCHMAN) and a proven management turnaround creates a buying opportunity. BSX is undervalued relative to its historical and projected earnings power, with catalysts from new product cycles and a long-tenured CEO. Competition from JNJ and Medtronic eroding PFA market share (projected drop from 58% to 48% by 2026); execution hiccups and recent guidance down; sector becoming capex-heavy and binary.

Apple will join the Russell 1000 Value Index, moving from pure growth to a blend of value and growth. Value-focused ETFs will be forced buyers of AAPL, driving incremental demand. Short-term bullish due to passive inflows from value indexes. Already large position in many funds; the effect may be diluted; growth funds may sell slightly, but net likely positive.

Alphabet will be removed from the Russell 1000 Value Index, meaning value-focused ETFs must sell GOOGL shares. Index rebalancing creates forced selling pressure from passive funds, often leading to short-term price dislocations. Sell into the expected selling wave before the final reconstitution on June 29. The market may have already priced in the change; short squeeze if buyers step in; actual net flows could be offset by growth index additions.